首页>
外国专利>
NITRIC OXIDE SYNTHESIS INHIBITORS FOR POTENTIATING THE ACTION OF PRESSOR AGENTS IN CERTAIN HYPOTENSIVE PATIENTS
NITRIC OXIDE SYNTHESIS INHIBITORS FOR POTENTIATING THE ACTION OF PRESSOR AGENTS IN CERTAIN HYPOTENSIVE PATIENTS
展开▼
机译:一氧化氮合成抑制剂可增强某些低血压患者的加压剂作用
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method for treatment of an animal for systemic hypotension induced by internal nitric oxide production caused by endotoxin or cytokines. The method involves administering an alpha 1 adrenergic agonist and an amount of an inhibitor of nitric oxide formation from arginine to restore vascular contractile sensitivity to alpha 1 adrenergic agonists. A preferred inhibitor of nitric oxide formation is an NG-substituted arginine having at least one hydrogen on a guanidino amino group replaced by another atomic or molecular species, including NG-aminoarginine, NG-nitroarginine, and NG-alkylarginines such as NG-methylarginine, NG-ethylarginine, NG-propylarginine and NG-butylarginine. Arginine derivative inhibitors are preferably of the L configuration and include pharmaceutically acceptable addition salts. Treatment of systemic hypotension in a patient which has been induced by chemotherapy with biologic response modifiers such as tumor necrosis factor or interleukin-2 may be likewise accomplished. Treatment of an animal for systemic hypotension induced by endotoxin, or other bacterial toxins, e.g., septic shock, may also be accomplished by treatment with alpha 1 adrenergic agonists and an inhibitor such as an arginine derivative, restoring vascular contractile sensitivity to the alpha 1 adrenergic agonists.
展开▼